March Biosciences

Clinical-stage biotechnology company developing next-generation CAR-T cell therapies for hematological cancers, focusing on T-cell lymphoma (TCL) and T-cell acute lymphoblastic leukemia (T-ALL).

Location
Houston, Texas, USA
Founded
2019
Investors
1
Categories
biotech, car-t, oncology, cell-therapy, hematological-cancers

Investors

NameLocationTypeStagesPortfolio
Portal InnovationsUSbiotech-focused-13